The Drug Screening Market Sales is estimated to develop at a considerable CAGR of 16.1% over the forecast period. The market is anticipated to be valued US$ 7.3 billion in 2023 and US$ 32.4 billion by 2033.
- Adult drug use is increasing, and Islamic nations that prohibit alcohol use are propelling the Drug Screening business. Furthermore, sophisticated screening and testing methods are compelling governments to invest in screening equipment.
- Enhancing high-throughput screening to uncover early-stage drug development is increasing the size of the Drug Screening Market, while additional high-content screening (HCS) is also adding to market growth.
- Another factor driving market expansion is the use of fragment-based drug discovery (FBDD) using a bottom-up approach that focuses on low-complexity molecules or fragments.
- The advanced offices and corporate structure feature drug testing and screening solutions, which also aid in the workforce’s cleanliness and consciousness. Governments in some countries also pressure corporations to implement similar drug-control strategies.
- The misuse of prescribed drugs and their trafficking has also fueled the demand for different drug control measures, flourishing the Drug Screening market.
Unlock growth potential with industry expertise. Download your market sample report now: https://www.futuremarketinsights.com/reports/sample/rep-gb-14265
Drug Screening Market Key Points:
- In terms of market share and CAGR, the United States market dominates the space. By 2033, the market is expected to be worth $11.5 billion USD. Between 2023 and 2033, the regional market is estimated to grow at a CAGR of 15.8%.
- Another big market is the Chinese Drug Screening market. During the predicted period, it grows at a stable CAGR of 15.4%. By 2033, the market is expected to be worth US$ 2.3 billion. The prevalence of drug use, along with rigorous government policies, is driving up demand for Drug Screening.
- Because of faster and more efficient drug testing methods, rapid testing devices are expected to thrive in the product and service type category. During the projection period, it is expected to grow at a CAGR of 15.8%.
- With a CAGR of 15.4% between 2023 and 2033, the drug testing devices laboratories segment leads the end user tally. The increase is ascribed to increased consumption and a lack of drug testing equipment in organisations as a result of decreased knowledge.
Competitive Landscape
The key players focus on providing Drug Screening solutions at cheaper prices while making these products portable, efficient, and effective. Key competitors also merge, acquire, and partner with other companies to increase the supply chain and distribution channel. The key players in the market are: Laboratory Corporation of America Holdings, Hoffmann -La Roche Ltd, BioMerieux SA, Bio-Rad Laboratories Inc., Biomedical Diagnostics
Drug Screening Market Report Available At a Discounted Price: https://www.futuremarketinsights.com/request-discount/rep-gb-14265
For instance:
- Bio-Rad Laboratories Inc has introduced its Bio-Rad which works on different concepts such as target discovery, lead discovery, preclinical research, and Progress development. This has extended the research and development programs for the brand.
- BioMerieux SA has completed its 60 years in the service. This has resulted in the biomerieux and InDevR partnership of 5 million. This will be the exclusive distributor in Europe of VaxArray.
Drug Screening Market Key Segments:
By Sample Type:
- Urine samples
- Breath Samples
- Oral Fluid Samples
- Hair Samples
- Other Samples
By Product and Service:
- Drug Screening
- Analytical Instruments
- Rapid Testing Devices
- Consumables
- Drug Screening Service
By End User:
- Drug Testing Laboratories
- Criminal Justice and Law Enforcement Agencies
- Hospitals
- Drug Treatment Centers
- Individual Users
- Pain Management Centers
- Schools and Colleges
- Workplaces
Customize Your Report Now: https://www.futuremarketinsights.com/customization-available/rep-gb-14265
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
